Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ACTAVIS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ACTAVIS
Dec-18
ELDER PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38016,126-   
Low Rs18810,818-   
Sales per share (Unadj.) Rs489.23,955.8-  
Earnings per share (Unadj.) Rs-3.2-1,274.2-  
Cash flow per share (Unadj.) Rs14.4416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs376.516,315.7-  
Shares outstanding (eoy) m20.54332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.63.4 17.0%   
Avg P/E ratio x-89.3-10.6 844.6%  
P/CF ratio (eoy) x19.732.3 61.0%  
Price / Book Value ratio x0.80.8 91.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8324,480,758 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,1790-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m10,0481,315,689 0.8%  
Other income Rs m25725,160 1.0%   
Total revenues Rs m10,3051,340,849 0.8%   
Gross profit Rs m2,92134,478 8.5%  
Depreciation Rs m361562,428 0.1%   
Interest Rs m2,75675,923 3.6%   
Profit before tax Rs m60-578,713 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m125-7,334 -1.7%   
Profit after tax Rs m-65-423,784 0.0%  
Gross profit margin %29.12.6 1,109.3%  
Effective tax rate %209.11.3 16,502.1%   
Net profit margin %-0.6-32.2 2.0%  
BALANCE SHEET DATA
Current assets Rs m9,240539,627 1.7%   
Current liabilities Rs m9,998477,372 2.1%   
Net working cap to sales %-7.54.7 -159.4%  
Current ratio x0.91.1 81.8%  
Inventory Days Days12820 655.0%  
Debtors Days Days60266 907.6%  
Net fixed assets Rs m13,642148,929 9.2%   
Share capital Rs m2060-   
"Free" reserves Rs m7,5280-   
Net worth Rs m7,7335,426,601 0.1%   
Long term debt Rs m4,8891,910,903 0.3%   
Total assets Rs m22,8828,483,012 0.3%  
Interest coverage x1.0-6.6 -15.4%   
Debt to equity ratio x0.60.4 179.5%  
Sales to assets ratio x0.40.2 283.1%   
Return on assets %11.8-4.1 -286.8%  
Return on equity %-0.8-7.8 10.8%  
Return on capital %22.3-4.8 -460.9%  
Exports to sales %3.10-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,754470,046 2.5%  
From Investments Rs m-561258,229 -0.2%  
From Financial Activity Rs m-6,762-806,740 0.8%  
Net Cashflow Rs m5,466-78,073 -7.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ELDER PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: ALKEM LABORATORIES  IND SWIFT LA  PLETHICO PHARMA  VINEET LABORATORIES  BHARAT PARENTALS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.